- Home
- NRXP vs APT Comparison
NRXP vs APT Comparison
Compare NRXP & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- APT
- Stock Information
- Founded
- NRXP 2015
- APT 1983
- Country
- NRXP United States
- APT Canada
- Employees
- NRXP N/A
- APT N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- NRXP Health Care
- APT
- Exchange
- NRXP Nasdaq
- APT Nasdaq
- Market Cap
- NRXP 58.5M
- APT 50.4M
- IPO Year
- NRXP N/A
- APT 1995
- Fundamental
- Price
- NRXP $3.58
- APT N/A
- Analyst Decision
- NRXP Strong Buy
- APT
- Analyst Count
- NRXP 5
- APT 0
- Target Price
- NRXP $31.40
- APT N/A
- AVG Volume (30 Days)
- NRXP 416.8K
- APT 23.2K
- Earning Date
- NRXP 11-13-2025
- APT 11-05-2025
- Dividend Yield
- NRXP N/A
- APT N/A
- EPS Growth
- NRXP N/A
- APT N/A
- EPS
- NRXP N/A
- APT 0.33
- Revenue
- NRXP N/A
- APT $58,562,000.00
- Revenue This Year
- NRXP N/A
- APT N/A
- Revenue Next Year
- NRXP $395.09
- APT N/A
- P/E Ratio
- NRXP N/A
- APT $14.52
- Revenue Growth
- NRXP N/A
- APT N/A
- 52 Week Low
- NRXP $1.10
- APT $4.06
- 52 Week High
- NRXP $6.01
- APT $6.20
- Technical
- Relative Strength Index (RSI)
- NRXP 67.97
- APT 47.74
- Support Level
- NRXP $3.19
- APT $4.75
- Resistance Level
- NRXP $3.84
- APT $4.84
- Average True Range (ATR)
- NRXP 0.22
- APT 0.11
- MACD
- NRXP 0.05
- APT -0.00
- Stochastic Oscillator
- NRXP 70.87
- APT 35.71
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.